Skip to main content
Erschienen in: Supportive Care in Cancer 2/2016

01.02.2016 | Original Article

Constipation in specialized palliative care: factors related to constipation when applying different definitions

verfasst von: E. Erichsén, A. Milberg, T. Jaarsma, M. Friedrichsen

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Context

For patients in palliative care, constipation is primarily a result of opioid treatment. Impacts from other factors related to constipation in palliative care are rarely studied.

Objectives

The aim was to identify factors related to constipation in patients in palliative care, and then to compare these factors between patients with different types of constipation and patients without constipation.

Methods

Cross-sectional data on constipation was collected with a 26-item questionnaire from 485 patients in 38 specialist palliative care units in Sweden. Three different constipation groups were used; MC ONLY, PC ONLY, and MC & PC. Logistic regression analyses were used to calculate odds ratios.

Results

Patients with <3 defecations/week, MC ONLY, (n = 36) had higher odds of being hospitalized, bed-restricted, in need of personal assistance for toilet visits, and of having a poor fluid intake. Patients with the perception of being constipated, PC ONLY, (n = 93) had higher odds of having poor appetite, hemorrhoids, hard stool, more opioid treatment, less laxative treatment and of being more dissatisfied with constipation information. Patients with both <3 defecations/week and a perception of being constipated, MC & PC, (n = 78) had higher odds of having cancer- disease.

Conclusion

There were several significant factors related to constipation with higher odds than opioid- treatment, for patients in palliative care, such as; hard stool, cancer diagnosis, dissatisfaction with information, low fluid intake, hemorrhoids, bed restriction, hospitalization, and need of personal assistance for toilet visits.
Literatur
1.
Zurück zum Zitat Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R (2009) The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (probe 1). Pain Med 10:35–42PubMedCrossRef Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R (2009) The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (probe 1). Pain Med 10:35–42PubMedCrossRef
2.
Zurück zum Zitat Friedrichsen M, Erichsen E (2004) The lived experience of constipation in cancer patients in palliative hospital-based home care. Int J Palliat Nurs 10:321–325PubMedCrossRef Friedrichsen M, Erichsen E (2004) The lived experience of constipation in cancer patients in palliative hospital-based home care. Int J Palliat Nurs 10:321–325PubMedCrossRef
3.
Zurück zum Zitat Clark K, Currow DC (2013) Constipation in palliative care: what do we use as definitions and outcome measures? J Pain Symptom Manag 45:753–762CrossRef Clark K, Currow DC (2013) Constipation in palliative care: what do we use as definitions and outcome measures? J Pain Symptom Manag 45:753–762CrossRef
5.
Zurück zum Zitat Bader S, Jaroslawski K, Blum HE, Becker G (2011) Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide: 201–211 Bader S, Jaroslawski K, Blum HE, Becker G (2011) Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide: 201–211
6.
Zurück zum Zitat Bookbinder M, McHugh ME (2010) Symptom management in palliative care and end of life care. Nurs Clin N Am 45:271–327CrossRef Bookbinder M, McHugh ME (2010) Symptom management in palliative care and end of life care. Nurs Clin N Am 45:271–327CrossRef
7.
Zurück zum Zitat Johnson MJ, Houghton T (2006) Palliative care for patients with heart failure: description of a service. Palliat Med 20:211–214PubMedCrossRef Johnson MJ, Houghton T (2006) Palliative care for patients with heart failure: description of a service. Palliat Med 20:211–214PubMedCrossRef
8.
Zurück zum Zitat Clark K, Urban K, Currow DC (2010) Current approaches to diagnosing and managing constipation in advanced cancer and palliative care. J Palliat Med 13:473–476PubMedCrossRef Clark K, Urban K, Currow DC (2010) Current approaches to diagnosing and managing constipation in advanced cancer and palliative care. J Palliat Med 13:473–476PubMedCrossRef
9.
Zurück zum Zitat Zhou L, Lin Z, Lin L, Wang M, Zhang H (2010) Functional constipation: implications for nursing interventions. J Clin Nurs 19:1838PubMedCrossRef Zhou L, Lin Z, Lin L, Wang M, Zhang H (2010) Functional constipation: implications for nursing interventions. J Clin Nurs 19:1838PubMedCrossRef
10.
Zurück zum Zitat Lamy O, Jenzer-Closuit A, Burckhardt P (2001) Hypercalcaemia of malignancy: an undiagnosed and undertreated disease. J Intern Med 250:73–79PubMedCrossRef Lamy O, Jenzer-Closuit A, Burckhardt P (2001) Hypercalcaemia of malignancy: an undiagnosed and undertreated disease. J Intern Med 250:73–79PubMedCrossRef
11.
Zurück zum Zitat Hjalte F, Berggren A-C, Bergendahl H, Hjortsberg C (2010) The direct and indirect costs of opioid-induced constipation. J Pain Symptom Manag 40:696–703CrossRef Hjalte F, Berggren A-C, Bergendahl H, Hjortsberg C (2010) The direct and indirect costs of opioid-induced constipation. J Pain Symptom Manag 40:696–703CrossRef
12.
Zurück zum Zitat Bosshard W, Dreher R, Schnegg J, Büla CJ (2004) The treatment of chronic constipation in elderly people: an update. Drugs Aging 21:911–930PubMedCrossRef Bosshard W, Dreher R, Schnegg J, Büla CJ (2004) The treatment of chronic constipation in elderly people: an update. Drugs Aging 21:911–930PubMedCrossRef
13.
Zurück zum Zitat Clark K, Smith JM, Currow DC (2012) The prevalence of bowel problems reported in a palliative care population. J Pain Symptom Manag 43:993-1000493–993-1000499 Clark K, Smith JM, Currow DC (2012) The prevalence of bowel problems reported in a palliative care population. J Pain Symptom Manag 43:993-1000493–993-1000499
14.
Zurück zum Zitat Garrigues V, Galvez C, Ortiz V, Ponce M, Nos P, Ponce J (2004) Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol 159:520–526PubMedCrossRef Garrigues V, Galvez C, Ortiz V, Ponce M, Nos P, Ponce J (2004) Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol 159:520–526PubMedCrossRef
15.
Zurück zum Zitat Yea T (2013) Randomized, double-blind. Placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manag 45:2–13CrossRef Yea T (2013) Randomized, double-blind. Placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manag 45:2–13CrossRef
16.
Zurück zum Zitat Iovino P, Chiarioni G, Bilancio G, Cirillo M, Mekjavic IB, Pisot R, Ciacci C (2013) New onset of constipation during long-term physical inactivity: a proof-of- concept study on the immobility-induced bowel changes. PLoS ONE 8(8):e72608 doi:10.1371PubMedPubMedCentralCrossRef Iovino P, Chiarioni G, Bilancio G, Cirillo M, Mekjavic IB, Pisot R, Ciacci C (2013) New onset of constipation during long-term physical inactivity: a proof-of- concept study on the immobility-induced bowel changes. PLoS ONE 8(8):e72608 doi:10.1371PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Richmond JP, Wright ME (2008) Establishing reliability and validity of a constipation risk assessment scale. J Orthop Nurs 12:139–150CrossRef Richmond JP, Wright ME (2008) Establishing reliability and validity of a constipation risk assessment scale. J Orthop Nurs 12:139–150CrossRef
18.
Zurück zum Zitat Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920–924PubMedCrossRef Lewis SJ, Heaton KW (1997) Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920–924PubMedCrossRef
19.
Zurück zum Zitat Garner S (2013) Prescribing for the elderly. Pract Nurs 43:19–25 Garner S (2013) Prescribing for the elderly. Pract Nurs 43:19–25
20.
Zurück zum Zitat Herz MJ, Kahan E, Zalevski S, Aframian R, Kuznitz D, Reichman S (1996) Constipation: a different entity for patients and doctors. Fam Pract 13:156–159PubMedCrossRef Herz MJ, Kahan E, Zalevski S, Aframian R, Kuznitz D, Reichman S (1996) Constipation: a different entity for patients and doctors. Fam Pract 13:156–159PubMedCrossRef
21.
Zurück zum Zitat Goodman M, Low J, Wilkinson S (2005) Constipation management in palliative care: a survey of practices in the United Kingdom. J Pain Symptom Manag 29:238–244CrossRef Goodman M, Low J, Wilkinson S (2005) Constipation management in palliative care: a survey of practices in the United Kingdom. J Pain Symptom Manag 29:238–244CrossRef
22.
Zurück zum Zitat Dhingra L, Shuk E, Grossman B, Strada A, Wald E, Portenoy A, Knotkova H, Portenoy R (2013) A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease. Palliat Med 27:447–456PubMedCrossRef Dhingra L, Shuk E, Grossman B, Strada A, Wald E, Portenoy A, Knotkova H, Portenoy R (2013) A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease. Palliat Med 27:447–456PubMedCrossRef
23.
Zurück zum Zitat Rhondali W, Nguyen L, Lynn Palmer J, Kang D-H, Hui D, Bruera E (2013) Self-reported constipation in patients with advanced cancer: a preliminary report. J Pain Symptom Manag 45:23–32CrossRef Rhondali W, Nguyen L, Lynn Palmer J, Kang D-H, Hui D, Bruera E (2013) Self-reported constipation in patients with advanced cancer: a preliminary report. J Pain Symptom Manag 45:23–32CrossRef
24.
Zurück zum Zitat McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, Wagner EH (2011) Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 61:50–62PubMedPubMedCentralCrossRef McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, Wagner EH (2011) Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 61:50–62PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Cash B, Mitchner NA, Ravyn D (2011) Confidence-based learning CME: overcoming barriers in irritable bowel syndrome with constipation. J Contin Educ Heal Prof 31:157–164CrossRef Cash B, Mitchner NA, Ravyn D (2011) Confidence-based learning CME: overcoming barriers in irritable bowel syndrome with constipation. J Contin Educ Heal Prof 31:157–164CrossRef
26.
Zurück zum Zitat Hoekstra J, de Vos R, van Duijn NP, Schadé E, Bindels PJ (2006) Using the symptom monitor in a randomized controlled trial: the effect on symptom prevalence and severity. J Pain Symptom Manag 31:22–30CrossRef Hoekstra J, de Vos R, van Duijn NP, Schadé E, Bindels PJ (2006) Using the symptom monitor in a randomized controlled trial: the effect on symptom prevalence and severity. J Pain Symptom Manag 31:22–30CrossRef
27.
Zurück zum Zitat Erichsen E, Milberg A, Jaarsma T, Friedrichsen M (2015) Constipation in specialized palliative care: prevalence, definition, and patient-perceived symptom distress. J Palliat Med. doi:10.1089/jpm.2014.0414 PubMed Erichsen E, Milberg A, Jaarsma T, Friedrichsen M (2015) Constipation in specialized palliative care: prevalence, definition, and patient-perceived symptom distress. J Palliat Med. doi:10.​1089/​jpm.​2014.​0414 PubMed
28.
Zurück zum Zitat Longstreth GF, Grant Thompson W, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Introduction: functional bowel disorders. Gastroenterology 130:1480–1491PubMedCrossRef Longstreth GF, Grant Thompson W, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Introduction: functional bowel disorders. Gastroenterology 130:1480–1491PubMedCrossRef
29.
Zurück zum Zitat Portenoy RK, McCarthy Lepore J, Kiyasu E, Sobel K, Coyle N, Thaler HT, Friedlander-Klar H, Kornblith AB, Kemeny N, Norton L, Scher H (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30:1326–1336CrossRef Portenoy RK, McCarthy Lepore J, Kiyasu E, Sobel K, Coyle N, Thaler HT, Friedlander-Klar H, Kornblith AB, Kemeny N, Norton L, Scher H (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30:1326–1336CrossRef
31.
Zurück zum Zitat Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers M, Bjorner JB, Lo C, Burman D, Swami N, Gagliese L, Rodin G, Zimmermann C, Fex A, Flensner G, Ek AC, Soderhamn O (2012) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64CrossRef Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers M, Bjorner JB, Lo C, Burman D, Swami N, Gagliese L, Rodin G, Zimmermann C, Fex A, Flensner G, Ek AC, Soderhamn O (2012) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64CrossRef
32.
Zurück zum Zitat Vellas B, Villars H, Abellani G, Soto MI, Rolland Y, Guigos Y, Morley JE, Chumlea W, Salva A, Ruebenstein LZ (2006) Overview of the MNA (R) -its history and challenges. J Nutr Health Aging 10:456–463PubMed Vellas B, Villars H, Abellani G, Soto MI, Rolland Y, Guigos Y, Morley JE, Chumlea W, Salva A, Ruebenstein LZ (2006) Overview of the MNA (R) -its history and challenges. J Nutr Health Aging 10:456–463PubMed
33.
Zurück zum Zitat Kyle G (2007) Continence journal. Norgine risk assessment tool for constipation. Nurs Times 103:48–49 Kyle G (2007) Continence journal. Norgine risk assessment tool for constipation. Nurs Times 103:48–49
35.
Zurück zum Zitat Ahmedzai SH, Boland J (2010) Constipation in people prescribed opioids. Clin Evid (Online) 2010 Ahmedzai SH, Boland J (2010) Constipation in people prescribed opioids. Clin Evid (Online) 2010
36.
Zurück zum Zitat Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2:22–27PubMedCrossRef Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2:22–27PubMedCrossRef
37.
Zurück zum Zitat Solheim TS, Blum D, Fayers PM, Hjermstad MJ, Stene GB, Strasser F, Kaasa S (2014) Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod? -analysis from a multicenter cross sectional study. Acta Oncol 53:539–546PubMedCrossRef Solheim TS, Blum D, Fayers PM, Hjermstad MJ, Stene GB, Strasser F, Kaasa S (2014) Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod? -analysis from a multicenter cross sectional study. Acta Oncol 53:539–546PubMedCrossRef
38.
Zurück zum Zitat Noiesen E, Trosborg I, Bager L, Herning M, Lyngby C, Konradsen H (2013) Constipation - prevalence and incidence among medical patients acutely admitted to hospital with a medical condition. J Clin Nurs 23:2295–2302PubMedCrossRef Noiesen E, Trosborg I, Bager L, Herning M, Lyngby C, Konradsen H (2013) Constipation - prevalence and incidence among medical patients acutely admitted to hospital with a medical condition. J Clin Nurs 23:2295–2302PubMedCrossRef
39.
40.
Zurück zum Zitat Holmes S (2011) Importance of nutrition in palliative care of patients with chronic disease. Nurs Stand 25:48–56CrossRef Holmes S (2011) Importance of nutrition in palliative care of patients with chronic disease. Nurs Stand 25:48–56CrossRef
41.
Zurück zum Zitat Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW, European Consensus Group on Constipation in Palliative Care (2008) The management of constipation in palliative care: clinical practice recommendations. Palliat Med 22:796–807PubMedCrossRef Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW, European Consensus Group on Constipation in Palliative Care (2008) The management of constipation in palliative care: clinical practice recommendations. Palliat Med 22:796–807PubMedCrossRef
42.
Zurück zum Zitat Hawley P, Barwich D, Kirk L (2011) Implementation of the Victoria bowel performance scale. J Pain Symptom Manag 42:946–953CrossRef Hawley P, Barwich D, Kirk L (2011) Implementation of the Victoria bowel performance scale. J Pain Symptom Manag 42:946–953CrossRef
Metadaten
Titel
Constipation in specialized palliative care: factors related to constipation when applying different definitions
verfasst von
E. Erichsén
A. Milberg
T. Jaarsma
M. Friedrichsen
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2831-5

Weitere Artikel der Ausgabe 2/2016

Supportive Care in Cancer 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.